Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.

MLA

Zając, Weronika, et al. “Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.” Cancers, vol. 15, no. 15, Aug. 2023, p. 3924. EBSCOhost, https://doi.org/10.3390/cancers15153924.

APA

Zając, W., Dróżdż, J., Kisielewska, W., Karwowska, W., Dudzisz-Śledź, M., Zając, A. E., Borkowska, A., Szumera-Ciećkiewicz, A., Szostakowski, B., Rutkowski, P., & Czarnecka, A. M. (2023). Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials. Cancers, 15(15), 3924. https://doi.org/10.3390/cancers15153924

Chicago

Zając, Weronika, Julia Dróżdż, Weronika Kisielewska, Weronika Karwowska, Monika Dudzisz-Śledź, Agnieszka E. Zając, Aneta Borkowska, et al. 2023. “Dedifferentiated Chondrosarcoma from Molecular Pathology to Current Treatment and Clinical Trials.” Cancers 15 (15): 3924. doi:10.3390/cancers15153924.